Importancia de los compuestos inorgánicos en el tratamiento de la leishmaniasis

Eric S. Gil; Luiz C. Cunha; Aurélia L.S. Gonçalves; Aparecido R. Souza; Ana C. Valderrama Negrón

Importancia de los compuestos inorgánicos en el tratamiento de la leishmaniasis

Eric S. Gil
, Luiz C. Cunha
, Aurélia L.S. Gonçalves
, Aparecido R. Souza
, Ana C. Valderrama Negrón

Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva

2 Citas (Scopus)

Resumen

Leishmaniasis is a parasitic disease caused by protozoan genus Leishmania. It is an endemic illness that encloses 80 countries, including some of the European continent and especially in development countries. In this revision the usual therapeutical options, focusing mechanisms of action and resistance, pharmacokinetics and toxicity are discussed . Additionally, the attempts for application of other chemotherapeutical drugs, especially organometalic substances derivatives of potencial active ligands, are also cited .

Título traducido de la contribución	The importance of inorganic compounds in leishmaniasis treatment
Idioma original	Español
Páginas (desde-hasta)	454-461
Número de páginas	8
Publicación	Latin American Journal of Pharmacy
Volumen	26
N.º	3
Estado	Publicada - 2007
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Palabras Clave

Action mechanisms
Antileishmaniasis
Leishmaniasis

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{623dc7c7cd9f4944bf06d999b9b5916f,

title = "Importancia de los compuestos inorg{\'a}nicos en el tratamiento de la leishmaniasis",

abstract = "Leishmaniasis is a parasitic disease caused by protozoan genus Leishmania. It is an endemic illness that encloses 80 countries, including some of the European continent and especially in development countries. In this revision the usual therapeutical options, focusing mechanisms of action and resistance, pharmacokinetics and toxicity are discussed . Additionally, the attempts for application of other chemotherapeutical drugs, especially organometalic substances derivatives of potencial active ligands, are also cited .",

keywords = "Action mechanisms, Antileishmaniasis, Leishmaniasis",

author = "Gil, \{Eric S.\} and Cunha, \{Luiz C.\} and Gon{\c c}alves, \{Aur{\'e}lia L.S.\} and Souza, \{Aparecido R.\} and \{Valderrama Negr{\'o}n\}, \{Ana C.\}",

note = "Funding Information: We are grateful to Sallie Rice for her helpful comments on this manuscript. This work was supported by US Department of Energy Small Business Innovation Research grant DE-FGD03-92ER81307.",

year = "2007",

language = "Espa{\~n}ol",

volume = "26",

pages = "454--461",

journal = "Latin American Journal of Pharmacy",

issn = "0326-2383",

publisher = "Colegio de Farmaceuticos de la Provincia de Buenos Aires",

number = "3",

}

TY - JOUR

T1 - Importancia de los compuestos inorgánicos en el tratamiento de la leishmaniasis

AU - Gil, Eric S.

AU - Cunha, Luiz C.

AU - Gonçalves, Aurélia L.S.

AU - Souza, Aparecido R.

AU - Valderrama Negrón, Ana C.

N1 - Funding Information: We are grateful to Sallie Rice for her helpful comments on this manuscript. This work was supported by US Department of Energy Small Business Innovation Research grant DE-FGD03-92ER81307.

PY - 2007

Y1 - 2007

N2 - Leishmaniasis is a parasitic disease caused by protozoan genus Leishmania. It is an endemic illness that encloses 80 countries, including some of the European continent and especially in development countries. In this revision the usual therapeutical options, focusing mechanisms of action and resistance, pharmacokinetics and toxicity are discussed . Additionally, the attempts for application of other chemotherapeutical drugs, especially organometalic substances derivatives of potencial active ligands, are also cited .

AB - Leishmaniasis is a parasitic disease caused by protozoan genus Leishmania. It is an endemic illness that encloses 80 countries, including some of the European continent and especially in development countries. In this revision the usual therapeutical options, focusing mechanisms of action and resistance, pharmacokinetics and toxicity are discussed . Additionally, the attempts for application of other chemotherapeutical drugs, especially organometalic substances derivatives of potencial active ligands, are also cited .

KW - Action mechanisms

KW - Antileishmaniasis

KW - Leishmaniasis

UR - https://www.scopus.com/pages/publications/34848872577

M3 - Artículo de revisión

AN - SCOPUS:34848872577

SN - 0326-2383

VL - 26

SP - 454

EP - 461

JO - Latin American Journal of Pharmacy

JF - Latin American Journal of Pharmacy

IS - 3

ER -

Importancia de los compuestos inorgánicos en el tratamiento de la leishmaniasis

Resumen

ODS de las Naciones Unidas

Palabras Clave

Otros archivos y enlaces

Huella

Citar esto